Last reviewed · How we verify
NCT05444140
A Feasibility Study of a Health Coaching Programme for Middle-aged Adults With Cardiometabolic Risk
NA trial testing Health coaching in Cardiometabolic Disease in 30 participants. Completed in 13 November 2021.
13 November 2021
Quick facts
| Lead sponsor | Chinese University of Hong Kong |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 30 |
| Start date | 1 April 2021 |
| Primary completion | 13 November 2021 |
| Estimated completion | 13 November 2021 |
| Sites | 1 location across Hong Kong |
Drugs / interventions tested
- Health coaching
Conditions studied
- Cardiometabolic Disease — all drugs for Cardiometabolic Disease →
- Health Coaching — all drugs for Health Coaching →
- Middle-aged Adults — all drugs for Middle-aged Adults →
- Primary Prevention — all drugs for Primary Prevention →
Sponsor
Chinese University of Hong Kong
Who can join
Adults 40 to 64, any sex, with Cardiometabolic Disease or Health Coaching. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cardiometabolic disease has been an increasing trend globally and remains the major cause of morbidity and mortality. Health coaching, a process of goal-oriented and client-centered partnership that is health-focus and through client enlightenment and empowerment, are generally effective for chronic disease management and prevention of complication. However, there is inconclusive result on the effects of health coaching in the primary prevention of cardiometabolic diseases. Therefore, this study aimed to assess the feasibility and acceptability of a theory-guided health coaching programme for middle-aged adults with cardiometabolic risk.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A protection motivation theory-guided telehealth coaching program for middle-aged adults with cardiometabolic risk: A feasibility trial.
Kwok ZC, Tam HL, Zee BC, Lo SW, et al · · 2025 · PMID 40128717 · DOI 10.1186/s12889-025-22238-w
Verify or expand the search:
- PubMed search for NCT05444140
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Health coaching
Trials testing the same drug.
- NCT06802172 — Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial · NA · recruiting
- NCT07099040 — Community-based Multi-domain Intervention to Detect and Delay Cognitive Decline in Community-dwelling Older Adults: A Pi · NA · not yet recruiting
- NCT06983431 — DIGITALIZATION OF PERSONALISED HEALTH RISK MANAGEMENT · NA · recruiting
- NCT05711654 — Chronic Obstructive Pulmonary Disease and Health Coaching · NA · unknown
- NCT05498415 — Feasibility, Acceptability, and Efficacy of the Sleep Move Stand Study · NA · completed
Other recruiting trials for Cardiometabolic Disease
Currently open trials in the same condition.
- NCT07076251 — Building Access to Food Through Systems and Solidarity (BASIS): A Subsidized and Culturally-adapted Produce Box Program · NA · recruiting
- NCT06585462 — Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity · Phase 1 · recruiting
Other Chinese University of Hong Kong trials
Trials by the same sponsor.
- NCT07508644 — RSV Vaccination to Reduce Recurrent AECOPD · Phase 4 · not yet recruiting
- NCT07230457 — Plasma MTB cfDNA Before Bronchoscopy · not yet recruiting
- NCT07288671 — Nostalgia Intervention on Alleviating Loneliness Amongst Older Adults · NA · not yet recruiting
- NCT07256457 — Postoperative Pulmonary Function Assessment Based on Deep Learning Study · NA · not yet recruiting
- NCT06904209 — Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05444140 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chinese University of Hong Kong
- Last refreshed: 5 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05444140.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing